ESTRO 2024 - Abstract Book

S705

Clinical - Breast

ESTRO 2024

Material/Methods:

Thirty in-depth interviews were carried out with women treated for localized breast cancer at the national oncology institute in Rabat. They were aged under 50 years old at the time of diagnosis and who were professionally active. Patients were interviewed during the quarterly monitoring consultation (12 months to three years after their diagnosis).

Results:

For several of these women, the professional situation deteriorated even before the work stoppage, with significant consequences on the compensation received during this stoppage. A total work stoppage of 6 months to 1 year was found in 83%. Then, even if the desire to work again is unanimous, their are several obstacles, we have found in our study : the after-effects of treatments forcing patients to give up old job (42%), a new professional aspirations after cancer (36%) and also the need to hide the illness and mobilize the social environment to find a new job in 23% of cases. In this work, we find that only 40% of patients returned to their old job after the end of treatment, while 20% had to change jobs in order to better adapt to their physical health and the after-effects of the treatments (lymphedema, upper limb pain with effort). The rest (40%) have not returned to work.

Conclusion:

Our results showed that breast cancer weakens the professional situation of affected women, sometimes from the time of diagnosis, and even before taking sick leave. This vulnerability can spread to other spheres of social life (living conditions, housing) and then makes reintegration and return to professional life even more difficult.

Keywords: Breast cancer, work, reintegration

2980

Digital Poster

>9 Months from preop S-PBI and surgery impacts PCR in breast cancer on a Phase I Trial (NCT04040569)

Asal S Rahimi 1 , Marilyn Leitch 2 , Deborah Farr 2 , Yulun Liu 3 , Mona Arbab 1 , Basak Dogan 1 , Prasanna Alluri 1 , Stephen Seiler 4 , Dong W Kim 5 , Rachel Wooldridge 2 , Nisha Unni 6 , Chika Nwachukwu 7 , Xingzhe Li 1 , You Zhang 1 , Weiguo Lu 1 , David D Parsons 1 , Anvy Nguyen 2 , Ina Patel 1 , Strahinja Stojadinovic 1 , Shohreh Bahrami 1 , Howard E Morgan 8 , Vanessa Igbeka 1 , Heather McArthur 6 , Sunati Sahoo 9 , Robert Timmerman 1 1 University of Texas Southwestern Medical Center, Radiation Oncology, Dallas, USA. 2 University of Texas Southwestern Medical Center, Surgical Oncology, Dallas, USA. 3 University of Texas Southwestern Medical Center,